Catechol-O-Methyltransferase and Cytochrome P-450 1B1 Polymorphisms and Endometrial Cancer Risk A Meta-analysis

被引:14
|
作者
Teng, Yue [1 ]
He, Caiyun [2 ]
Zuo, Xiaohang [3 ]
Li, Xu [1 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Translat Med, Xian 710061, Peoples R China
[2] China Med Univ, Key Lab Canc Control Liaoning Prov, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, Affiliated Hosp 1, Shenyang, Peoples R China
[3] 323 Hosp Chinese Peoples Liberat Army, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
COMT; CYP1B1; Polymorphism; Endometrial cancer; Meta-analysis; CYP1B1 GENE POLYMORPHISMS; P4501B1; ALPHA; EXPRESSION; BETA;
D O I
10.1097/IGC.0b013e3182849e0d
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Disordered metabolism of estrogen is believed to play a significant role in endometrial carcinogenesis. Recently, a number of studies have been conducted to identify the role of estrogen-related gene polymorphism in endometrial cancer risk, generating conflicting conclusions. This meta-analysis aimed to assess the association between genetic polymorphisms involving estrogen metabolic enzymes and endometrial cancer risk. Methods: A systematic search of 6 databases was conducted. Fourteen studies on the association of COMT (catechol-O-methyltransferase) Val158Met, CYP1B1 Leu432Val, and CYP1B1 Asn453Ser polymorphisms with endometrial cancer risk were identified, enrolling a total of 4283 cancer cases and 7094 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the relationship. Results: In CYP1B1 Leu432Val(rs1056836) analysis, the heterozygous genotype (CG) demonstrated an increased risk for endometrial cancer (Val/Leu vs Leu/Leu: pooled OR, 1.11; 95% CI, 1.01-1.23; P = 0.039; I-2 = 10.5%; (Val/Val + Val/Leu) vs Leu/Leu: pooled OR, 1.19; 95% CI, 1.03-1.38; P = 0.017; I-2 = 54.7%). As for CYP1B1 Asn453Ser(rs1800440) polymorphism, a decreased risk was observed in G allele compared with A allele (Ser vs Asn: pooled OR, 0.82; 95% CI, 0.72-0.94; P = 0.005; I-2 = 0.0%), and heterozygous genotype also showed a decreased risk compared with normal genotype (Ser/Asn vs Asn/Asn: pooled OR, 0.81; 95% CI, 0.69-0.95; P = 0.011; I-2 = 0.0%). As for COMT Val158Met (rs4680) polymorphism, the heterogeneous genotype showed a decreased risk for endometrial cancer compared with the common homogenous genotype in a fixed-effect model in Asian population (Met/Val vs Val/Val: pooled OR, 0.83; 95% CI, 0.70-0.98; P = 0.033; I-2 = 29.2%), whereas no positive results are found in other subgroups or models. Conclusions: COMT Val158Met was seen to show a decreased risk for endometrial cancer in Asian population. CYP1B1 Leu432Val and Asn453Ser polymorphisms demonstrated an increased and decreased risk for endometrial cancer, respectively. Further large and comprehensive studies in various populations with more detailed individual data are needed to confirm our findings.
引用
收藏
页码:422 / 430
页数:9
相关论文
共 50 条
  • [1] Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and endometrial cancer risk in Chinese women
    Tao, Meng Hua
    Cai, Qiuyin
    Xu, Wang Hong
    Kataoka, Nobuhiko
    Wen, Wanqing
    Zheng, Wei
    Xiang, Yong Bing
    Zhang, Zuo-Feng
    Shu, Xiao Ou
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (12) : 2570 - 2573
  • [2] Cytochrome P450 1b1 and catechol O-methyltransferase genetic polymorphisms and endometrial cancer susceptibility
    McGrath, M
    Hankinson, SE
    Arbeitman, L
    Colditz, GA
    Hunter, DJ
    De Vivo, I
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S72 - S72
  • [3] Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in chinese women:: Results from the Shanghai breast cancer study and a meta-analysis
    Wen, WQ
    Cai, QY
    Shu, XO
    Cheng, JR
    Par, F
    Pierce, L
    Gao, YT
    Zheng, W
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) : 329 - 335
  • [4] Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk
    Wen, Wanqing
    Ren, Zefang
    Shu, Xiao Ou
    Cai, Qiuyin
    Ye, Chuanzhong
    Gao, Yu-Tang
    Zheng, Wei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (05) : 917 - 920
  • [5] Cytochrome P4501B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility
    McGrath, M
    Hankinson, SE
    Arbeitman, L
    Colditz, GA
    Hunter, DJ
    De Vivo, I
    CARCINOGENESIS, 2004, 25 (04) : 559 - 565
  • [6] Haplotypes of cytochrome P450 1B1 (CYP1B1) and catechol-O-methyltransferase (COMT) and risk of breast cancer among Polish women.
    Gaudet, Mia M.
    Chanock, Stephen
    Lissowska, Jolanta
    Berndt, Sonja I.
    Brinton, Louise A.
    Welch, Robert
    Yeager, Meredith
    Bardin-Mikolajczak, Alicja
    Peplonska, Beata
    Garcia-Closas, Monterrat
    CANCER RESEARCH, 2006, 66 (08)
  • [7] Cytochrome P450 1A1 Gene Polymorphisms and Endometrial Cancer Risk A Meta-Analysis
    Sergentanis, Theodoros N.
    Economopoulos, Konstantinos P.
    Choussein, Souzana
    Vlahos, Nikos F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (02) : 323 - 331
  • [8] FOUR POLYMORPHISMS IN CYTOCHROME P450 1B1 (CYP1B1) GENE AND BREAST CANCER RISK: A META-ANALYSIS
    Economopoulos, K. P.
    Sergentanis, T. N.
    ANNALS OF ONCOLOGY, 2010, 21 : 54 - 54
  • [9] Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis
    Konstantinos P. Economopoulos
    Theodoros N. Sergentanis
    Breast Cancer Research and Treatment, 2010, 122 : 545 - 551
  • [10] Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis
    Economopoulos, Konstantinos P.
    Sergentanis, Theodoros N.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (02) : 545 - 551